Severe Community-Acquired Pneumonia (sCAP)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Severe Community-Acquired Pneumonia (sCAP) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT05722938

Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)

The main objective of the trial is to assess the efficacy and safety of trimodulin as adjunctive treatment to standard of care (SoC) compared to placebo plus So…

United States590 participantsStarted 2023-09-09

Treatment: Trimodulin, Placebo (human albumin 1%)

All recent trials (9 shown)

Not Yet RecruitingNot Applicable

NCT07301099

Epidemiology and Current Practices in Severe Community-Acquired Pneumonia

The goal of this observational study is to learn more about severe community-acquired pneumonia (sCAP) in adults who need hospital or intensive care. This type…

Colombia2,588 participantsStarted 2026-02-01

Not Yet RecruitingPhase 2/3

NCT07152587

Randomized Adaptive Platform Trial of Pathogen-Directed Anti-inflammatory Therapy in Severe Community-Acquired Pneumonia…

Severe community-acquired pneumonia (sCAP) has a high mortality rate of 25-50%. Excessive host inflammatory responses contribute to poor outcomes. Corticosteroi…

Location not specified1,500 participantsStarted 2025-09-08

Treatment: Low dose steroids, Moderate dose steroids

Severe Community-Acquired Pneumonia (sCAP)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)

All recent trials (9 shown)

Epidemiology and Current Practices in Severe Community-Acquired Pneumonia

Randomized Adaptive Platform Trial of Pathogen-Directed Anti-inflammatory Therapy in Severe Community-Acquired Pneumonia…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)

All recent trials (9 shown)

Epidemiology and Current Practices in Severe Community-Acquired Pneumonia

Randomized Adaptive Platform Trial of Pathogen-Directed Anti-inflammatory Therapy in Severe Community-Acquired Pneumonia…

ESCAPE10: Epidemiology, Risk Factors, and Outcomes of Severe Community-acquired Pneumonia in Elderly PatientsAcquired Pn…

Appropriateness of Antibiotic Combination Therapy for Severe Community-acquired Pneumonia in South Korea

Molecular Biomarkers for Sepsis

A Phase 1b/2a Study of the Safety and Pharmacokinetics of Rhu-plasma Gelsolin in Hospitalized Subjects With CAP

Safety and Efficacy Study of BT086 to Evaluate Adjunctive Therapy in sCAP

Study to Evaluate Two Diagnostic Strategies for the Treatment of Severe Community Acquired Pneumonia (SCAP)